Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Verve Therapeutics Q4 EPS USD -0.58

Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 13.08 million.

Q4 net income USD -50.035 million

Recent news on Verve Therapeutics

See all news